Related Experiment Video

Updated: May 18, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Camptothecins in tumor homing via an RGD sequence mimetic

Domenico Alloatti1, Giuseppe Giannini, Loredana Vesci

  • 1Corporate R&D, sigma-tau Industrie Farmaceutiche Riunite SpA, Pomezia, Italy.

Bioorganic & Medicinal Chemistry Letters
|September 11, 2012
PubMed

Insights

A novel RGD peptide mimetic conjugated to camptothecins improved cancer drug delivery. Compound 8 demonstrated enhanced stability and prolonged half-life in vivo, suggesting improved therapeutic potential for cancer treatment.

Area of Science:

  • Oncology
  • Drug Delivery
  • Medicinal Chemistry

Background:

  • Camptothecins are potent anticancer agents with limitations in their therapeutic index.
  • Integrins are cell surface receptors implicated in tumor progression and metastasis.
  • Targeted drug delivery strategies aim to enhance efficacy and reduce systemic toxicity.

Purpose of the Study:

  • To develop novel camptothecin conjugates using an RGD peptide mimetic for targeted cancer therapy.
  • To evaluate the in vitro and in vivo efficacy of these conjugates against cancer cell lines with varying integrin expression.
  • To assess the pharmacokinetic properties and stability of the lead conjugate.

Main Methods:

  • Synthesis and conjugation of four RGD peptide mimetic-camptothecin derivatives.
  • In vitro cytotoxicity assays against human ovarian carcinoma (A2780) and prostate cancer (PC3) cell lines.
  • In vitro adhesion assays to vitronectin.
  • Stability studies in PBS and rat plasma over 24 hours.
  • In vivo pharmacokinetic evaluation of the lead compound (Compound 8) compared to irinotecan.

Main Results:

  • Conjugate derivatives were synthesized and characterized.
  • Compound 8 exhibited potent in vitro activity against integrin-overexpressing A2780 cells.
  • Compound 8 demonstrated superior stability in PBS and rat plasma.
  • In vivo studies revealed a prolonged half-life for Compound 8 compared to irinotecan.

Conclusions:

  • RGD peptide mimetic conjugation can enhance the therapeutic potential of camptothecins.
  • Compound 8 shows promise as a targeted anticancer agent with improved pharmacokinetic properties.
  • Further investigation is warranted to explore the in vivo anti-tumor efficacy of Compound 8.

More Related Videos

Competitive Homing Assays to Study Gut-tropic T Cell Migration10:25

Competitive Homing Assays to Study Gut-tropic T Cell Migration

Published on: March 1, 2011

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments09:12

Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments

Published on: March 28, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...